A Phase I Study of Weekly Topotecan and Paclitaxel in Previously Treated Epithelial Ovarian Carcinoma Patients

By Homesley H.   Benigno B.   Williams J.   Vaccarello L.  

Gynecologic Oncology, Vol. 87, Iss. 2, 2002-11 ,pp. : 171-177

Academic Press

Access to resources Recommend Favorite

Profound Thrombocytopenia in Previously Treated Patients with Recurrent Ovarian Carcinoma Receiving Topotecan

By Cass I.   Kuo D.Y.   Fields A.L.   Runowicz C.D.   Goldberg G.L.  

Gynecologic Oncology, Vol. 69, Iss. 2, 1998-05 ,pp. : 175-176

Elsevier

Access to resources Recommend Favorite

Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer

By Polee M.B.   Verweij J.   Siersema P.D.   Tilanus H.W.   Splinter T.A.W.   Stoter G.   Van der Gaast A.  

European Journal of Cancer, Vol. 38, Iss. 11, 2002-07 ,pp. : 1495-1500

Elsevier

Access to resources Recommend Favorite

Repetitive High-Dose Topotecan, Carboplatin, and Paclitaxel with Peripheral Blood Progenitor Cell Support in Previously Untreated Ovarian Cancer: Results of a Phase I Study

By Prince H.M.   Rischin D.   Quinn M.   Allen D.   Planner R.   Neesham D.   Gates P.   Davison J.  

Gynecologic Oncology, Vol. 81, Iss. 2, 2001-05 ,pp. : 216-224

Elsevier

Access to resources Recommend Favorite

A Dose Escalating Study of Oxaliplatin and High Dose Weekly Leucovorin and 5-Fluorouracil in Patients with Advanced Solid Tumors

By Souglakos John   Kakolyris Stylianos   Vardakis Nikolaos   Androulakis Nikolaos   Mavroudis Dimitrios   Vamvakas Lambos   Kouroussis Charalambos   Agelaki Sophia   Saridaki Zacharenia   Georgoulias Vassilis  

Cancer Investigation, Vol. 23, Iss. 6, 2005-09 ,pp. : 505-510

Informa Healthcare

Access to resources Recommend Favorite